SKI Market

A+| A| A-|

Indian Indices

Sensex

74,775.74 -1,092.06
( -1.44%)

Global Indices

Nasdaq

51,069.65 379.68
(0.75%)

Dow Jones

7,605.10 20.47
(0.27%)

Hang Seng

66,385.32 1,692.20
(2.62%)

Nikkei 225

10,420.12 -5.84
(-0.06%)

Forex

USD-INR

95.93 0.16
(0.16%)

EUR-INR

111.54 0.10
(0.09%)

GBP-INR

128.71 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Premier Roadlines Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

92837

INE0CFG01012

38.9563538

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PRLIND

9.46

145.06

EPS(TTM)

Face Value()

Div & Yield %

6.71

Back

radhagobind commercial ltd

Ipca Laboratories consolidated net profit rises 31.49% in the December 2025 quarter

Feb 13,2026

Net profit of Ipca Laboratories rose 31.49% to Rs 326.27 crore in the quarter ended December 2025 as against Rs 248.14 crore during the previous quarter ended December 2024. Sales rose 6.55% to Rs 2392.50 crore in the quarter ended December 2025 as against Rs 2245.37 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2392.50	2245.37	7
OPM %	22.29	20.62	-
PBDT	535.92	466.38	15
PBT	428.33	367.92	16
NP	326.27	248.14	31

74,775.74 -1,092.06 ( -1.44%)

51,069.65 379.68 (0.75%)

7,605.10 20.47 (0.27%)

66,385.32 1,692.20 (2.62%)

10,420.12 -5.84 (-0.06%)

95.93 0.16 (0.16%)

111.54 0.10 (0.09%)

128.71 -0.01 (-0.01%)

0.60 0.00 (0.17%)